Delivery Order SPE2DB24D2205-SPE2DB25FEFSG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $13,581.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in a quantity of 90 units, with a contract ceiling value of $26,852.27. This delivery order represents a competitive, non-set-aside award issued under a firm fixed price structure with an ultimate completion date of July 22, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 4 mg tablets (90-count) with a ceiling value of $1,171.70. This competitive, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the...
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a $4,126.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 22, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Candesartan Cilexetil is an angiotensin II receptor blocker commonly prescribed...
- The Defense Logistics Agency awarded a delivery order valued at $3,084.47 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 4 mg tablets in a quantity of 90-count units. This contract was awarded on July 18, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 21, 2025. The award represents a non-competitive, non-set-aside delivery order and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Candesartan cilexetil is an...
- The Defense Logistics Agency awarded a $1,506.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this contract represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Candesartan Cilexetil 16 mg tablets (90-count supply) with a ceiling value of $2,106.86. This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an approximately $1 billion vehicle running through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.69 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units) with a firm fixed price structure. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation and represents a competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,150.25 firm fixed price delivery order is for the supply of 4566611121 - Candesartan Cilexetil 32 mg tablets, with an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFSGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count) with a ceiling value of $53,240.96. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Candesartan cilexetil is an angiotensin II receptor blocker used in the treatment of hypertension and heart failure, indicating this delivery supports military and federal healthcare system pharmaceutical needs. This award is a child delivery order under AmerisourceBergen's $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains significant federal contract activity through the Defense Logistics Agency's Medical Supply Chain, supplying a broad range of generic and brand-name medications, vaccines, and medical supplies to support the Defense Health Agency and other federal healthcare systems worldwide. The competitively awarded delivery orders under this IDC vehicle demonstrate the contractor's established capability to meet federal pharmaceutical procurement requirements at various transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.2k | 8/1/25 |